Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00517036 · ClinicalTrials.gov registry record · Phase 3
Omega-3 Fatty Acids for Treating Adults With Major Depression
A Phase 3 study, sponsored by Cedars-Sinai Medical Center.
- Completed
- Registry status
- Phase 3
- Development phase
- 196
- Enrollment target
NCT00517036 is a Phase 3 study that has completed, run by Cedars-Sinai Medical Center. The registered enrollment target is 196 participants.
The verdict
NCT00517036, a Phase 3 study, has completed, sponsored by Cedars-Sinai Medical Center.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 196 participants
- Enrollment target
Study Summary
This study will test the effectiveness of two different kinds of omega-3 fatty acid dietary supplements in treating the symptoms of major depression.
Interventions
- DIETARY_SUPPLEMENT Placebo comparator
- DIETARY_SUPPLEMENT EPA omega-3 fatty acid
- DIETARY_SUPPLEMENT DHA omega-3 fatty acid
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 196 participants |
| Start Date | 2006-07 |
| Est. Completion | 2011-01 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00517036
The ClinicalTrials.gov registry entry for NCT00517036 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 196 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Cedars-Sinai Medical Center, which has 339 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Placebo comparator is the first listed.
NCT00517036 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00517036 about?
NCT00517036 is a clinical study titled "Omega-3 Fatty Acids for Treating Adults With Major Depression". This study will test the effectiveness of two different kinds of omega-3 fatty acid dietary supplements in treating the symptoms of major depression.
What is the current status of trial NCT00517036?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 196 participants. The study started on 2006-07. Estimated completion is 2011-01.
What interventions are being tested in trial NCT00517036?
The interventions under investigation include: Placebo comparator (DIETARY_SUPPLEMENT), EPA omega-3 fatty acid (DIETARY_SUPPLEMENT), DHA omega-3 fatty acid (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT00517036?
This trial is sponsored by Cedars-Sinai Medical Center, which has 339 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.